<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 30, 1999
Transworld Healthcare, Inc.
-------------------------------
(Exact name of Registrant as specified in its charter)
New York
--------------
(State or other jurisdiction of incorporation)
1-11570 13-3098275
- --------------------- ----------------------
(Commission File Number) (I.R.S. Employer Identification No.)
555 Madison Avenue, New York, NY 10122
- -----------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 750-0064
------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE>
Item 5. Other Events
Transworld Healthcare, Inc. (the "Company") announced on April 29, 1999
that its common stock, which had been trading on the Nasdaq National
Market, will begin trading on the American Stock Exchange effective
April 30, 1999. The ticker symbol for the stock will be TWH. The change
was necessitated by non-compliance with Nasdaq's rule requiring that
shares quoted on the National Market trade at a price of $5 or more.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Transworld Healthcare, Inc.
---------------------------
(Registrant)
Date: April 30, 1999 By: /s/ Wayne A. Palladino
----------------------------
Senior Vice President and
Chief Financial Officer
3
